RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+30.25%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$574M
AUM Growth
+$574M
(+21%)
Cap. Flow
-$15.7M
Cap. Flow
% of AUM
-2.73%
Top 10 Holdings %
Top 10 Hldgs %
75.45%
Holding
31
New
3
Increased
10
Reduced
12
Closed
4
Top Buys
| 1 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$28.1M |
| 2 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$10.9M |
| 3 |
Regenxbio
RGNX
|
$8.77M |
| 4 |
Apyx Medical
APYX
|
$3.85M |
| 5 |
PTC Therapeutics
PTCT
|
$3.82M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$49M |
| 2 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$11.6M |
| 3 |
Atara Biotherapeutics
ATRA
|
$8.55M |
| 4 |
Omeros
OMER
|
$4.73M |
| 5 |
Universal Health Services
UHS
|
$3.15M |
Sector Composition
| 1 | Healthcare | 96.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alnylam Pharmaceuticals
ALNY
$58.5B
| $73.2M | 12.75% | 623,338 -417,269 | -40% | -$49M |
|
|
2
PTC Therapeutics
PTCT
$3.92B
| $69.9M | 12.18% | 3,495,143 +190,929 | +6% | +$3.82M |
|
3
Bristol-Myers Squibb
BMY
$96B
| $52.7M | 9.19% | 827,512 +52,837 | +7% | +$3.37M |
|
|
4
Regenxbio
RGNX
$451M
| $50.7M | 8.83% | 1,539,005 +266,235 | +21% | +$8.77M |
|
|
AVXS
5
DELISTED
AveXis, Inc. Common Stock
AVXS
| $45.2M | 7.88% | 467,667 -119,450 | -20% | -$11.6M |
|
|
LJPC
6
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $36.3M | 6.33% | 1,044,307 -63,072 | -6% | -$2.19M |
|
|
ACHN
7
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $35.2M | 6.13% | 7,839,766 +6,249,312 | +393% | +$28.1M |
|
8
Arbutus Biopharma
ABUS
$711M
| $32.7M | 5.69% | 5,266,280 +56,457 | +1% | +$350K |
|
|
AGEN
9
Agenus
AGEN
$133M
| $18.6M | 3.24% | 4,218,520 -58,936 | -1% | -$260K |
|
|
CORI
10
DELISTED
Corium International, Inc.
CORI
| $18.6M | 3.23% | 1,675,479 +43,478 | +3% | +$482K |
|
11
BioCryst Pharmaceuticals
BCRX
$1.74B
| $17.4M | 3.03% | 3,324,705 -9,253 | -0.3% | -$48.5K |
|
|
OXFD
12
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $17.3M | 3.02% | 1,032,370 +185,453 | +22% | +$3.12M |
|
|
BLUE
13
DELISTED
bluebird bio
BLUE
| $14.3M | 2.49% | 104,078 -305 | -0.3% | -$41.9K |
|
14
OraSure Technologies
OSUR
$242M
| $12.1M | 2.1% | 535,707 -52,549 | -9% | -$1.18M |
|
|
DRNA
15
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $12M | 2.08% | 2,078,991 | – | – |
|
16
Tactile Systems Technology
TCMD
$297M
| $10.9M | 1.9% | 353,216 -19,086 | -5% | -$591K |
|
|
MYOK
17
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $10.9M | 1.9% | +253,962 | New | +$10.9M |
|
|
18
Atara Biotherapeutics
ATRA
$84.6M
| $10.9M | 1.89% | 656,018 -516,726 | -44% | -$8.55M |
|
19
Masimo
MASI
$7.59B
| $10.5M | 1.82% | 120,900 +20,000 | +20% | +$1.73M |
|
|
VIVE
20
DELISTED
VIVEVE MED INC
VIVE
| $7.72M | 1.34% | 1,473,028 +233,585 | +19% | +$1.22M |
|
|
VRAY
21
DELISTED
ViewRay, Inc.
VRAY
| $5.88M | 1.02% | 1,020,462 +256,127 | +34% | +$1.48M |
|
|
FSTX
22
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $4.2M | 0.73% | 249,095 -905 | -0.4% | -$15.2K |
|
|
23
Apyx Medical
APYX
$75.3M
| $3.85M | 0.67% | +1,139,600 | New | +$3.85M |
|
|
ZYNE
24
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $1.67M | 0.29% | +200,000 | New | +$1.67M |
|
|
GBT
25
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $817K | 0.14% | 26,310 -67 | -0.3% | -$2.08K |
|